To test whether these events might contribute to TGFβ induced accelerated c-Myc HCC progression, we first examined the changes of tumor related immune milieu in EGFP and TGFβ1 expressing c-Myc liver tumors. The gene discussed is TGFB1; the disease is neoplasm.